Thirdly, that any effect is limited to a subset of BRCA variants (e.g., the Ovarian Cancer Cluster Region which is associated with a much higher relative risk of ovarian cancer than other variants in BRCA1 or BRCA2 (Rebbeck et al., 2015)) and that the variant profile differs in different cohorts. Here, BRCA2 is linked to ovarian cancer.